A study published last week in the journal Vaccines found that among males ages 18-25, Moderna’s COVID-19 vaccine was associated with 8%-52% more hospitalizations for vaccine-associated myocarditis and pericarditis than the number of COVID-19 hospitalizations it prevented. The findings contradict the risk-benefit analysis conducted by the FDA.

https://childrenshealthdefense.org/defender/heart-damage-moderna-mrna-covid-vaccine-fda-understated-risk-study/?

AND

A Reanalysis of the FDA’s Benefit–Risk Assessment of Moderna’s mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection

https://www.mdpi.com/2076-393X/14/2/165